The neisserial Lip antigen is a conserved antigen associated with the pathogenic Neisseria species, and is composed of multiple repeats of a consensus pentapeptide. A series of monoclonal antibodies reacting with meningococcal Lip antigen were subjected to epitope mapping, using solid-phase synthetic peptides based on the consensus repeat sequence. The antibodies were found to recognize different continuous epitopes based on the consensus sequence. One monoclonal antibody was utilized in affinity chromatography to obtain purified Lip antigen and the antigen was used for immunization of mice. The resulting antisera did not recognize Lip antigen on Western blots but reacted specifically with Lip antigen in immune precipitation experiments, indicating that the predominant polyclonal immune response was directed against conformational epitopes. Despite the diversity of both continuous and conformational epitopes recognized by the antibodies produced, none of the antibodies demonstrated the ability to promote complement-mediated bactericidal activity. Thus despite its initial apparent promise as a potential vaccine candidate the case for the inclusion of Lip antigen in vaccine formulation cannot be supported at present.
Introduction
Disease due to Neisseria meningitidis remains an important cause of morbidity and mortality. While purified capsular polysaccharide is used in immunoprophylaxis against disease caused by serogroups A, C , Y and W135 (Peltola et al., 1985) , these vaccines provide little protection in infants and young children (Gold et al., 1979; Reingold et al., 1985) , the age group who are most susceptible to attack (Goldschneider et al., 1969) . Furthermore, there is currently no polysaccharide vaccine against organisms of serogroup B, the most common cause of epidemic meningococcal disease in the USA and Europe (Peltola, 1983) .
The shortcomings of polysaccharide vaccines have led to the investigation of other surface antigens such as outer-membrane proteins, lipopolysaccharide (LPS) and pili as vaccine candidates. Meningococcal outer membranes contain four classes of outer-membrane proteins, named 1 , 2 or 3 , 4 and 5 in order of decreasing apparent molecular mass on SDS-PAGE. Although these proteins are immunogenic during disease and after vaccination (Poolman et al., 1983; Wedege & Froholm, 1986) attempts at the use of the outer-membrane proteins for immunoprophylaxis have been hampered by their antigenic diversity. The class 5 proteins and pili are subject to inter-strain antigenic variation during the course of an infection (Poolman et al., 1980; Tinsley & Heckels, 1986) while the class 2/3 and class 1 proteins show differences between strains that are responsible for serotype and subtype differences respectively (Frasch et al., 1985) . The ideal of a meningococcal vaccine that would stimulate immunity to a wide variety of antigenically distinct strains focuses attention on more conserved surface antigens.
One such candidate, the highly conserved class 4 protein, has recently been shown to be capable of inducing 'blocking' antibodies which are not only nonbactericidal but also inhibit the bactericidal effect of antibodies directed against other surface antigens (Munkley et al., 1991) . Such antibodies would therefore be expected to be antagonistic to vaccine development. Using a monoclonal antibody (H.8) raised against gonococcal outer membranes Cannon et al. (1984) reported the detection of a surface-exposed determinant, of apparent molecular mass 20 kDa, which was common to all pathogenic neisseriae and absent from most nonpathogenic species. This antigen, initially termed H.8 antigen, although readily detected on Western blots could not be detected by staining following SDS-PAGE. An antigen with similar properties but varying in apparent molecular mass between 18 and 30 kDa was subsequently reported by two other groups (Virji et al., 1985 ; Zollinger et al., 1985) . Subsequent biochemical and genetic studies have identified the H.8 antigen as a lipoprotein, based on multiple imperfect repeats of a consensus pentapeptide lacking aromatic amino acids (Baehr et al., 1989; Woods et al., 1989) . As a result of its lipoprotein nature the antigen has been formally designated as Lip, the product of the lip gene .
The Lip antigen's conservation, its association with pathogenic species and immunogenicity during gonococcal and meningococcal disease (Black et al., 1985) has led to interest in its potential as a component of an antiNeisseria vaccine. However, limited data are available on the potential protective effect of antibodies directed against Lip antigen and some of the results reported are contradictory. One report found passive protection against experimental meningococcal infection by the H.8 anti-lip mAb . More recent studies report that one anti-Lip mAb may promote complement-mediated killing of some gonococcal strains (Schweinle et al., 1989) , while another is ineffective against meningococcal strains (Bhattacharjee et al., 1990) .
In order to investigate the potential of the Lip antigen as a vaccine component, mAbs recognizing distinct epitopes on the antigen have been examined for their potential bactericidal effect on meningococci. In addition the Lip antigen has been purified and used to elicit polyclonal antisera, whose specificity and bactericidal activity have been compared to those of the mAbs.
Methods
Bacterial strains and growth conditions. Neisseria meningitidis strain MC50 (group C, non-typable, subtype P1.16) was from the cerebrospinal fluid of a patient with meningococcal meningitis. Isolation and subsequent culture conditions have been described previously (Tinsley & Heckels, 1986) .
Monoclonal antibodies. mAbs reactive with Lip antigen obtained following immunization of mice with outer membranes from Neisseria gonorrhoeae strain P9 were SM70 (y2b), SM71 (yl), SM72 (y3) and SM73 (y3) (Virji & Heckels, 1988) . The mAb SM300 (y2b), directed against the P1.16 epitope on meningococcal class 1 protein, was obtained following immunization with outer membranes of strain MC50 (McGuinness et al., 1991) . The ascites fluids used all contained between 4 and 6 mg IgG ml-I .
SDS-PAGE and Western blotting. SDS-PAGE was carried out on gels containing a linear gradient of 10-25% (w/v) acrylamide gradient as described previously (Heckels, 198 1) . Proteins were visualized by staining with PAGE-Blue 83, carried out as described by Fairbanks et al. (1971) , or by silver staining performed according to the method of Hitchcock & Brown (1983) .
For Western blotting after electrophoretic separation of cell components by SDS-PAGE, gels were soaked for 30min in 2 0 m~-Tris, pH 10-4, containing 20% (v/v) methanol. Electrophoretic transfer of antigens to nitrocellulose was carried out with a 'Semi-dry multi-gel electroblotter' (Ancos, Denmark) using the method of Khyse-Andersen (1984) . Immune detection of electrophoretically transferred antigens was carried out with 251-Protein A as described previously (Tinsley & Heckels, 1986) .
Immuneprecipitation reaction. Non-radioactive immune precipitation was based on the radio-immune precipitation assay of Diaz et al. (1984) . Meningococci were suspended in PBS containing 0.3 % Empigen BB (Albright & Wilson, Cumbria) and 0.1% SDS (RIP buffer) for 2 h at 37 "C, then the insoluble material was removed by centrifugation at lOOOOOg for 30 min. The soluble antigen (80 pg protein in lOOpl) was mixed with 40pl of a 1/10 dilution of either ascitic fluid containing mAb or polyclonal antiserum, together with a suspension (50 pl) of agarose-linked goat anti-mouse IgG (Sigma). The mixture was incubated at 4 "C for 1.5 h with end-over-end rotation. The beads were recovered by centrifugation, washed with RIP buffer then boiled in SDS-PAGE dissociating buffer to solubilize the precipitated antigen, which was then subjected to SDS-PAGE. The identity of the precipitated antigens was determined by Western blotting with appropriate antisera.
Analytical techniques. (i) Measurement of protein concentration.
Protein concentrations were measured by the Lowry method or by the more sensitive micro-bicinchoninic acid (micro-BCA, Pierce) assay (Smith et al., 1985) .
(ii) Quantitative dot-blot analysis for the Lip antigen. Samples containing the antigen in solution were serially diluted into PBS and samples (3 pl) from each dilution were applied to a sheet of nitrocellulose. Non-specific protein binding was blocked by incubation in BSA solution, and the nitrocellulose was incubated with anti-Lip mAb followed by 251-Protein A as for Western blotting. Equal-sized squares containing each spot of antigen were cut from the nitrocellulose and bound radioactivity was measured by a gamma counter. For each sample the bound radioactivity was plotted against log(dilution), to give a graph similar to that obtained from a conventional ELISA and allowing comparison of the concentrations of antigen in different samples. The absolute amount of antigen present was subsequently calculated by comparison with a known amount of purified Lip antigen.
(iii) Amino acid analysis. Samples containing between 0.5 and 2 pg of protein or a standard mixture of amino acids were hydrolysed by vapour-phase HCl at 110 "C in an evacuated vessel for 24 h. Analysis was carried out using an 'amino-chrome' kit (Ciba Corning) in which the amino acids were reacted with dabsylation reagent then separated by reverse-phase HPLC according to the manufacturer's instructions.
(iv) N-terminal sequence analysis of purijied Lip antigen. Purified antigen (20 pg protein) was dissolved in trifluoroacetic acid and subjected to N-terminal sequence analysis using an Applied Biosystems 477A pulsed liquid-phase protein sequencer with on-line PTH amino acid identification.
Epitope mapping with solid-phase oligopeptides. Oligopeptides corresponding to the inferred sequence of the Lip antigen (Baehr et al., 1989) were synthesized on polyethylene pins using a commercially available kit (CRB, Cambridge) and pentafluorophenyl active esters of fluorenylmethoxycarbonyl-L-amino acids (Milligen) as described previously (Virji & Heckels, 1989) . Immunological reactivity of the peptides was assayed by ELISA as previously described and was always observed with duplicate peptides.
In vitro, complement-mediated bactericidal assay. The procedure used was as described by Munkley at al. (1991) . Meningococci were harvested after 19 h growth, centrifuged for 2 min at 60g to remove aggregates of cells and diluted in PBSB (Difco) containing 1 % (w/v) decomplemented foetal calf serum (Gibco). The complement source was guinea-pig serum (Gibco) at a final concentration of 10% (v/v). The suspensions were incubated with serial dilutions of antibody at 37 "C for 30min. The bactericidal activities of each dilution of antibody were expressed as the percentage killing, defined as [l -{number of survivors in wells containing complement divided by number of survivors in wells containing decomplemented serum}] x 100.
Afinity chromatography. The anti-Lip mAb SM70 was purified from murine ascitic fluid by HPLC on a hydroxyapatite column (HPHT; Bio-Rad) using a linear gradient of 10-350 mM-sodium phosphate buffer, pH 6.8, as described previously (Virji et al., 1987) . The purified immunoglobulin (10 mg) was dialysed against 0.1 M-SodiUm bicarbonate, pH 8-3, containing 0.5 M-sodium chloride and was coupled to 0-86 g CNBr-activated Sepharose CL4B (Pharmacia) using the manufacturer's recommended procedure, Meningococcal cells were solubilized by incubation in RIP buffer at 37 "C for 2 h, since this treatment had been found to solubilize almost all of the antigen, and it was known not to disrupt antibody-antigen interactions (Zak et al., 1983) . Solubilized antigen containing 40 mg whole-cell protein was applied to the affinity column in a total volume of 18 ml. Unbound material was removed by extensive washing with RIP buffer, then the column was eluted with 0.5 M-NaCl adjusted to pH 11-0 with NH40H. The eluted fractions were immediately neutralized by gassing with C 0 2 until the pH fell below 8.0.
Production of anti-Lip polyclonal antisera. Affinity-purified antigen was adsorbed to aluminium hydroxide gel (Alhydrogel ; Superphos, Denmark) by incubation at 4°C for 16 h. Mice were initially immunized intraperitoneally with 2-10 pg purified antigen adsorbed to 250 yg Alhydrogel followed by four booster immunizations at intervals of approximately two weeks. Controls were similarly immunized with Alhydrogel alone.
Results

Properties of anti-Lip monoclonal antibodies
The four mAbs all reacted in ELISA with outer membranes of strain MC50 and on Western blotting produced a broad band of molecular mass approximately 18.6 kDa. Since it was possible that the mAbs were directed against a single epitope, synthetic oligopeptides were used in an attempt to define the epitopes recognized by the mAbs. Decapeptides were synthesized, corresponding to the predicted amino acid sequence of the Lip antigen, and incorporating the changes observed in the consensus sequence (Baehr et al., 1989) . The oligopeptides were assayed for immunological reactivity with each of the anti-Lip mAbs. In each case reactivity was detected with a number of peptides corresponding to different regions of the Lip antigen and significant differences in reactivity of the individual mAbs could be observed (Fig. 1) . Antibodies SM70 and SM71 reacted with all peptides containing the sequence EAPAAE, SM73 reacted with only a limited subset of these peptides, and SM72 reacted only with peptides containing the sequence PAAEAP. These data were not sufficient to define the minimum specificities of the antibodies, but since the recognized sequences all lay within the consensus repeating sequence, a further set of peptides based on this sequence were synthesized. A series of overlapping decapeptides were synthesized, based on the consensus sequence, with adjacent peptides differing by a single amino acid residue. Similar sets of octamers, heptamers, hexamers, tetramers and trimers were also synthesized. Each mAb produced a distinctive pattern of reactivity with the peptides, which permitted definition of the different epitopes recognized (Fig. 2) . Thus the minimum epitope recognized by mAb SM70 was the tetrapeptide EAPA since all longer peptides reactive with SM70 contained this sequence whilst those that did not were non-reactive. Similarly the minimum epitopes recognized by mAbs SM71 and SM72 could be defined as EAPAAE and PAAEAP respectively. The minimum epitope recognized by SM73 could be defined as (A)EAPAAE(A), requiring an alanine residue at one or both ends of the peptide for optimal reactivity.
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Purijication of a meningococcal Lip antigen by afinity chromatography
To examine the polyclonal immune response to Lip required a source of purified antigen. Preliminary experiments using selective extraction, gel filtration and ion-exchange chromatography (Strittmatter & Hitchcock, 1986 ; Zollinger et at., 1985) produced only low yields of impure material. The availability of specific anti-Lip mAbs was therefore used in an affinity purification of Lip antigen. Analysis of the fractions from the column (Fig. 3a) showed that virtually all of the protein detected passed directly through the column (fractions 3-4) . The Lip antigen profile, measured by dot-blot assay, revealed low levels of antigen in the initial fractions and that specific elution occurred on application of the NaCl/NH,OH (fractions 11-12). SDS-PAGE analysis of the fractions showed that whole-cell protein was confined to fractions 3-4 but no protein was detected by PAGE-Blue staining in the tracks containing specifically desorbed Lip antigen. On silver staining using the method of Hitchcock & Brown (1983) a weak yellow/green band corresponding to the expected 18.6 kDa position of the Lip antigen could be seen on overloaded gels (Fig. 3b) . On Western blots this band reacted strongly with mAb SM70. A similar band was also observed on blots which were reacted with rabbit antisera raised against complete outer membranes from the same strain; in this case no other bands were detected, confirming the purity of the antigen preparation (Fig. 3c) .
Amino acid analysis revealed that the purified antigen was rich in alanine, proline and glutamine or glutamate, and lacked sulphur-containing residues. The amino acid analysis also permitted quantification of the Lip antigen : the specifically eluted fractions contained 0.7 mg protein, measured as total amino acids, and this represented an overall yield of 50% as measured by dot-blot assay. When N-terminal amino acid sequence analysis was performed on the purified material no free amino terminus could be detected, as would be predicted with an amino-terminal-substituted lipoprotein.
Production and characterization of polyclonal anti-Lip antisera
Mice were injected intraperitoneally with 5 pg purified Lip antigen adsorbed to 120 pl aluminium hydroxide gel, at intervals of two weeks. After four injections all mice showed the presence of specific anti-Lip antibodies, with a titre of 1-3 x lo6 as measured by E L S A with purified antigen. No detectable antibodies were present in preimmune sera or in mice immunized with aluminium hydroxide alone. The immune sera also showed a significant, although lower, increase to a titre of 5 x lo5 against outer membranes from strain MC50. However, despite the significant increases in ELISA titre, the sera showed no detectable reaction with Lip antigen on Western blotting with outer membranes from strain MC50. SDS-PAGE of affinity-purified antigen subjected to silver staining: 1, outer-membrane preparation before affinity purification; 2, purified antigen eluted by 0.5 M-NaC1 pH 11.0, (the arrowhead indicates the position of weakly staining band at 18.6 kDa). (c) Western blot of purified material using polyclonal antisera raised against outer membranes of strain MC50: 1, outer-membrane preparation before affinity purification; 2, purified antigen eluted by 0.5 M-NaCI pH 11.0. A possible explanation for the apparent discrepancy between the results of the ELISA and Western blotting experiments was that the antibodies induced by immunization with purified Lip recognized conformational rather than continuous epitopes on the antigen. Previous studies with meningococcal pili have demonstrated that such antibodies can be detected by immune precipitation of radiolabelled antigens under non-denaturing conditions . Such experiments were not possible with the Lip antigen since preliminary experiments showed that it labelled very poorly by the method of Bolton & Hunter (1973) and not at all using chemical oxidation. An alternative method of immunoprecipitation was devised which would detect anti-Lip antigen reactivity, despite the fact that it could not be radiolabelled. Immune precipitation was carried out using the mouse polyclonal anti-Lip sera and solubilized antigen from strain MC50. The precipitated material was then subjected to SDS-PAGE and the presence of precipitate obtained with the anti-Lip sera (Fig. 4a) . A control immune precipitation reaction carried out with mAb SM70 itself also precipitated Lip antigen but no bands were detected in precipitates with serum from mice immunized with aluminium hydroxide alone. In a second experiment to investigate the specificity of the immune response to the Lip antigen the immune precipitate obtained with the anti-Lip sera was subjected to Western blotting using rabbit anti-outer-membrane serum as the detection system. A single band corresponding to Lip antigen was detected (Fig. 4b) , thus confirming that the immune response to the purified Lip antigen was specific for the antigen and directed mainly against conformational and not linear epitopes.
In vitro, complement-mediated bactericidal assays
The four mAbs were investigated to determine whether they were capable of activating complement-mediated bacteriolysis. No bactericidal effect was observed with any of the antibodies, in contrast with a positive control directed against class 1 protein, which killed over 90% of the bacteria at similar concentrations of antibody (Fig.  5) . Similarly the polyclonal mouse anti-Lip antiserum was tested for its ability to promote complement bactericidal killing of strain MC50. No significant bactericidal effect could be detected at a range of dilutions tested, in contrast to results obtained with antisera raised against outer membranes of the same strain (Fig. 5 ).
Discussion
The conserved nature of the Lip antigen and its occurrence in pathogenic but not non-pathogenic Neisseria species has focused attention on its potential for immunization against meningococcal infection. The Lip antigen is highly immunogenic both during natural infection and on immunization of laboratory animals. Indeed it was this latter property that led to its identification with the advent of mAb studies Zollinger et al., 1985; Virji et al., 1985) since previous studies had failed to detect the antigen because of its inability to stain following SDS-PAGE. Cloning and sequencing of the lip gene from two gonococcal strains has revealed a predicted lipoprotein structure comprising 13 or 14 imperfect repeats of a consensus pentapeptide AAEAP and with an N-terminal cystine substituted by lipid (Woods et al., 1989; Baehr et al., 1989) .
The nature of the structure of the Lip antigen with its multiple repeats of a consensus pentapeptide suggests that it must contain only a very limited number of distinct potential antigenic determinants. Indeed it seemed possible that diverse mAbs with Lip specificity might be restricted to recognition of a single determinant. However, the ability to synthesize large numbers of peptides on solid-phase supports now permits the detailed mapping of epitopes recognized by mAbs. Using the consensus repeat sequence for epitope mapping revealed that each of the mAbs used in these studies recognized distinct overlapping epitopes.
The availability of mAbs also permitted affinity purification of the Lip antigen. Previous studies have purified Lip antigen by selective extraction followed by a combination of ion-exchange and size-exclusion chromatography (Strittmatter & Hitchcock, 1986; Bhattacharjee et al., 1988 ). In the current study similar methods produced low yields of antigen contaminated by significant amounts of other outer-rnembrane components. In contrast, the use of mAb SM70 in affinity chroma-tography produced antigen containing no impurities which could be detected by silver staining. The amino acid composition of the purified Lip antigen was in accord with previous studies (Strittmatter & Hitchcock, 1986; Bhattacharjee et al., 1988) in that it showed an abundance of alanine, glutamate and proline.
The purity of the antigen was also supported by the failure to detect, in antisera raised against it, antibodies to other meningococcal components either by Western blotting or on immune precipitation. The failure of the anti-Lip to react with the antigen itself in Western blots, in contrast to its reactivity in immune precipitation, demonstrated that the predominant immune response was directed against conformational rather than continuous epitopes. This specificity is distinct from that of the mAbs which have been obtained following immunization with meningococci or outer membranes ( Despite the conserved nature of the Lip antigen and the association of its expression with virulence in Neisseria, the evidence of its ability to induce a protective immune response is contradictory. Initial studies reported that an anti-Lip mAb produced passive protection in an infant mouse model of meningococcal infection. but subsequent studies suggested that the observed protection was due to non-specific immune stimulation by contaminating LPS (Woods et al., 1987) . It is generally accepted that since the presence of serum bactericidal activity correlates with immunity to meningococcal disease (Goldschneider et al., 1969 ) the most desirable attribute of potential vaccine candidates is the ability to induce antibodies which promote complement-mediated bactericidal killing. In a study of gonococcal strains Schweinle et al. (1989) reported that one anti-Lip mAb was bactericidal for two strains while Bhattacharjee et al. (1990), using another mAb, found no killing of three different meningococcal strains tested. Given the highly conserved and repetitive structure of the Lip antigen it initially seemed likely that the mAbs used in such experiments might be directed against a single immunodominant epitope. However, the mAbs used in the present study were shown to recognize distinct structural motifs based on the consensus repeat sequence, while the polyclonal sera produced by immunization with purified antigen recognized conformational epitope(s) on the antigen. Despite the diversity of epitopes recognized, none of the antibodies showed significant bactericidal activity.
The reason for the failure of anti-Lip antibodies to promote bacterial killing is not clear but may be related to limited exposure of the antigen on the surface of meningococci. Initial studies suggested that Lip antigen was readily accessible on the surface of gonococci (Hitchcock et al., 1985) but more recent studies using immune electron microscopy suggest that the antigen may only be accessible on approximately 20% of gonococci in urethral exudates (Robinson et al., 1987) . For whatever reason, the results in the current study suggest that despite its initial apparent promise as a potential vaccine candidate, the case for the inclusion of Lip antigen in vaccine formulation cannot be supported at present, although it should be noted that the immune reponse in humans may be different to that of laboratory animals.
